| Schedule of related party transactions |
| |
|
Three Months Ended
March 31,
|
| |
|
2018 |
|
2017 |
| |
|
|
|
|
| Sale and purchase of plasma |
|
|
|
|
|
|
|
|
| Product
revenue |
|
$ |
2,328,291 |
|
|
$ |
2,092,215 |
|
| Purchases |
|
|
195,018 |
|
|
|
182,386 |
|
| |
|
|
|
|
|
|
|
|
| License revenue |
|
|
35,708 |
|
|
|
35,708 |
|
| |
|
|
|
|
|
|
|
|
| Interest expense |
|
|
225,000 |
|
|
|
— |
|
| |
|
March
31, |
|
December
31, |
| |
|
2018 |
|
2017 |
| Accounts receivable |
|
$ |
726,409 |
|
|
$ |
1,245,677 |
|
| Prepaid expenses and other current assets |
|
|
133,356 |
|
|
|
— |
|
| Accounts payable |
|
|
94,256 |
|
|
|
139,939 |
|
| Accrued expenses |
|
|
380,607 |
|
|
|
314,820 |
|
| Note payable, net of discount |
|
|
14,850,048 |
|
|
|
14,842,396 |
|
| Accrued interest |
|
|
290,000 |
|
|
|
65,000 |
|
| Deferred revenue |
|
|
2,654,325 |
|
|
|
2,690,033 |
|
|